Background illustration for clinical trials search

Ovarian Cancer Clinical Trials

Browse 1,660 ovarian cancer clinical trials enrolling across the United States and Canada. Search by city or state to find one near you.

Filter
1

A Single Arm Pilot Trial of a Social Network Intervention

for
Cancer
Location: Rochester NY
Sponsor: University of Rochester

Sex: All

Age: 60+

Code: NCT05745038

Recruiting

Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction

for
Malignant Solid Neoplasm
Location: Philadelphia PA, Buffalo NY
Sponsor: Roswell Park Cancer Institute

Sex: All

Age: 18+

Code: NCT06306638

Phase 1, Phase 2, Recruiting

Safety Study of Camptothecin-20-O-Propionate Hydrate (CZ48)

for
Malignant Lymphoma of Extranodal and/or Solid Organ Site,
Location: San Antonio TX
Sponsor: Cao Pharmaceuticals Inc.

Sex: All

Age: 18+

Code: NCT02575638

Phase 1, Recruiting

Ablative Radiotherapy to Restrain Every Metastasis Safely Treatable (ARREST-2): A Randomized Phase II/III Trial

for
Metastatic Cancer
Location: Montreal, London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Sex: All

Age: 18+

Code: NCT05508464

Recruiting

Interprofessional Pharmacogenomics (IPGx) Registry and Repository

for
Diabetes, Cholesterol, Cancer, Blood Pressure Disorders,
Location: Bryan TX
Sponsor: Texas A&M University

Sex: All

Age: 18+

Code: NCT06726590

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Dose Escalation and Expansion Study Evaluating ODC-IL2 in Adult Patients With Advanced or Metastatic Solid Tumors

for
Advanced Solid Tumors, Metastatic Solid Tumors
Location: Scottsdale AZ
Sponsor: Trutino Biosciences Inc.

Sex: All

Age: 18+

Code: NCT06770764

Phase 1, Recruiting

BBO-11818 in Adult Subjects With KRAS Mutant Cancer

for
Non-Small Cell Lung Cancer, NSCLC,
Location: Boston MA, New Haven CT, New York NY, Tampa FL,
Sponsor: TheRas, Inc., d/b/a BBOT (BridgeBio Oncology Therapeutics)

Sex: All

Age: 18+

Code: NCT06917079

Phase 1, Recruiting

A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)

for
Recurrent or Metastatic Solid Tumors
Location: Westbury NY, White Plains NY, New York NY, Fairfax VA,
Sponsor: Daiichi Sankyo

Sex: All

Age: 18+

Code: NCT06330064

Phase 1, Phase 2, Recruiting

Phase II Study of Asciminib for Second-line Treatment of Chronic Phase Chronic Myeloid Leukemia

for
Malignant Solid Tumors
Location: Houston TX
Sponsor: M.D. Anderson Cancer Center

Sex: All

Age: 18+

Code: NCT06629584

Phase 2, Recruiting

Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.

for
Advanced Solid Tumor
Location: Boston MA
Sponsor: Oncomatryx Biopharma S.L.

Sex: All

Age: 18+

Code: NCT05547321

Phase 1, Recruiting

Hyper-Personalized Medicine Using Patient Derived Xenografts (PDXovo) for Metastatic Solid Tumors

for
Kidney Neoplasm, Carcinoma, Renal Cell, Metastatic Solid Tumor
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre

Sex: All

Age: 18+

Code: NCT04602702

Recruiting

Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer

for
Cancer, Cancer Risk
Location: Albuquerque NM
Sponsor: New Mexico Cancer Research Alliance

Sex: All

Age: 18+

Code: NCT03977402

Recruiting

Trial to Evaluate the Safety & Tolerability of JBZ-001 in Pts With Advanced Solid and Hematological Malignancies

for
Solid Tumor
Location: Columbus OH, West Valley City UT
Sponsor: Jabez Bioscience, Inc

Sex: All

Age: 18+

Code: NCT06801002

Phase 1, Recruiting

Impact of the Coronavirus (COVID-19) on Patients With Cancer

for
Cancer, COVID-19
Location: Stanford CA
Sponsor: Stanford University

Sex: All

Age: 18 - 70+

Code: NCT04330521

Recruiting

SNV1521 in Participants With Advanced Solid Tumors

for
Advanced Solid Tumor
Location: New Haven CT, Philadelphia PA, Toronto, Nashville TN,
Sponsor: Synnovation Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06220864

Phase 1, Recruiting

Patient-Derived Xenografts to Reduce Cancer Health Disparities

for
Bladder Carcinoma, Gastric Carcinoma,
Location: Orange CA, Sacramento CA
Sponsor: University of California, Davis

Sex: All

Age: 21 - 70+

Code: NCT04410302

Recruiting

Psilocybin Therapy in Advanced Cancer

for
Advanced Cancer
Location: New York NY, Aurora CO
Sponsor: NYU Langone Health

Sex: All

Age: 21 - 70+

Code: NCT05398484

Phase 2, Phase 3, Recruiting

Testing eSCCIP: An eHealth Psychosocial Intervention for English and Spanish Speaking Parents of Children With Cancer

for
Pediatric Cancer
Location: Wilmington DE
Sponsor: Nemours Children's Clinic

Sex: All

Age: 0+

Code: NCT05294302

Recruiting

An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.

for
Cancer, Metabolic Disease, Aneurysm, Neurologic Disorder
Location: Watertown MA
Sponsor: Hercules

Sex: All

Age: 18+

Code: NCT06212479

Recruiting

Prospectively Defining Metastatic Pancreatic Ductal Adenocarcinoma Subtypes by Comprehensive Genomic Analysis

for
Cancer, Pancreatic Cancer
Location: Vancouver
Sponsor: British Columbia Cancer Agency

Sex: All

Age: 18+

Code: NCT02869802

Recruiting

What is ovarian cancer?

Ovarian cancer begins in or near the ovaries. About 9 in 10 cases are epithelial, and most of those are high grade serous tumors that research now shows usually start in the fallopian tubes rather than the ovary. Rarer types begin in the egg cells or in hormone producing cells. It is hard to catch early. The ovaries sit deep in the pelvis, and early symptoms like bloating, pelvic or back pain, feeling full quickly, and urinary urgency are vague and common. The most frequent sign at diagnosis is abdominal swelling from fluid, which means the cancer is already advanced.

Treatment has changed. Surgery to remove as much tumor as possible, followed by platinum chemotherapy, is still the foundation. Since 2014 PARP inhibitor pills have been used to delay recurrence in BRCA mutated and similar tumors, and testing every patient for these mutations is now standard. In 2022 the first antibody drug conjugate for ovarian cancer was approved for platinum resistant disease, with full approval in 2024. Prevention has moved too. Because most cancers start in the tubes, removing only the fallopian tubes during other pelvic surgery is being tested as a way to prevent cancer without early menopause.

Ovarian cancer shares its inherited risk genes with breast, pancreatic, and prostate cancer. Our cancer treatment guide explains how targeted therapies work.

Types of ovarian cancer clinical trials

How is ovarian cancer diagnosed and tested?

Who can participate in ovarian cancer clinical trials?

The stages of ovarian cancer, and why they matter for trials

How to enroll in an ovarian cancer clinical trial